Danske Bank (OTCMKTS:DNKEY – Get Free Report) has received a consensus rating of “Moderate Buy” from the five research firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company.
Several brokerages have recently weighed in on DNKEY. Barclays reiterated an “overweight” rating on shares of Danske Bank in a research note on Wednesday, December 10th. Morgan Stanley reiterated an “overweight” rating on shares of Danske Bank in a research report on Monday, November 24th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danske Bank in a report on Monday, November 3rd. Finally, Citigroup reaffirmed a “buy” rating on shares of Danske Bank in a research note on Tuesday, October 14th.
View Our Latest Research Report on Danske Bank
Danske Bank Trading Down 1.9%
Danske Bank (OTCMKTS:DNKEY – Get Free Report) last issued its quarterly earnings data on Friday, October 31st. The financial services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The firm had revenue of $2.15 billion for the quarter, compared to analysts’ expectations of $2.15 billion. Danske Bank had a net margin of 40.42% and a return on equity of 13.01%. Analysts predict that Danske Bank will post 1.84 EPS for the current year.
About Danske Bank
Danske Bank A/S is a major Danish banking group headquartered in Copenhagen. The firm traces its origins to the 19th century and has grown through mergers and organic expansion into one of the region’s largest financial institutions. Its shares are primarily listed on Nasdaq Copenhagen, and American investors may encounter the bank’s ADR trading on the U.S. over-the-counter market under the symbol DNKEY.
The bank provides a broad range of financial products and services across retail, commercial and institutional segments.
See Also
- Five stocks we like better than Danske Bank
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Danske Bank Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danske Bank and related companies with MarketBeat.com's FREE daily email newsletter.
